| USD millions | FY2023 | FY2024 | FY2025 | Trend | YoY |
|---|---|---|---|---|---|
| Revenue | 9.8 | 10.9 | 18.6 | +70.9% | |
| Cost of revenue | 0.1 | 0.2 | 0.0 | −100.0% | |
| Gross profit | 9.6 | 10.7 | 18.6 | +73.6% | |
| Research & development | 12.7 | 19.2 | 53.8 | +180.0% | |
| Selling, general & administrative | — | — | 41.7 | — | |
| Selling & marketing | — | — | 0.0 | — | |
| Operating expenses | 16.0 | 23.9 | 95.4 | +298.6% | |
| Operating income | (6.4) | (13.2) | (76.8) | −481.1% | |
| Interest expense | 0.0 | 0.0 | 0.0 | — | |
| Interest income | 0.0 | 0.0 | 0.0 | — | |
| Other income / expense | — | — | (0.0) | — | |
| Pre-tax income | (6.4) | (13.2) | (76.8) | −481.3% | |
| Income tax | 0.0 | 11.9 | (0.1) | −101.2% | |
| Net income | (6.4) | (25.1) | (76.7) | −205.2% | |
| Discontinued operations | — | — | 0.0 | — | |
| Other net income adjustments | — | — | 0.0 | — | |
| EPS, basic (per share) | (0.37) | (1.47) | (4.48) | −205.2% | |
| EPS, diluted (per share) | (0.37) | (1.47) | (4.48) | −205.2% | |
| EBITDA | (6.2) | (13.0) | (76.5) | −486.4% | |
| Depreciation & amortization | 0.1 | 0.2 | 0.3 | +87.8% | |
| Weighted average shares (shares) | 17,114,391 | 17,114,391 | 17,114,000 | −0.0% | |
| Weighted average diluted shares (shares) | 17,114,391 | 17,114,391 | 17,114,000 | −0.0% | |
| Gross margin | 98.6% | 98.4% | 100.0% | +1.6 pts | |
| Operating margin | −65.4% | −121.3% | −412.6% | −291.3 pts | |
| Net margin | −65.4% | −230.5% | −411.9% | −181.3 pts |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
